The effect of OCT-2 inhibitor Daclatasvir on Metformin pharmacokinetics and pharmacodynamics at two dose levels: A Bayesian approach using Markov-Chain Monte Carlo simulations

The effect of OCT-2 inhibitor Daclatasvir on Metformin pharmacokinetics and pharmacodynamics at two dose levels: A Bayesian approach using Markov-Chain Monte Carlo simulations

Renal Organic Cation Transporter 2 (OCT2) plays a major role in metformin elimination. Daclatasvir, a Direct-Acting Antiviral (DAA), is an OCT2 inhibitor. Our study aimed to assess the potential interaction of daclatasvir with metformin pharmacokinetics and pharmacodynamics at two metformin doses. T...

Full description

Bibliographic Details
Main Authors: Mohamed Raslan, Lamia Elwakeel, Sara Shahin
Format: Article
Language:English
Published: Ain Shams University 2022-12-01
Series:Archives of Pharmaceutical Sciences Ain Shams University
Subjects:
metformin
daclatasvir
oct2
pharmacokinetics
pharmacodynamics
mcmc
Online Access:https://aps.journals.ekb.eg/article_281273.html

Internet

https://aps.journals.ekb.eg/article_281273.html

Similar Items